Osteoporosis (Fracture Risk)
Drug Cuts Fracture Risk for Women with Osteoporosis
Published in Women's Health Weekly, October 25th, 1999
Vertebral fractures in particular are a common consequence of osteoporosis and are considered a hallmark of osteoporosis in postmenopausal women, since the condition is hard to detect until there is a fracture.
An important goal of research into osteoporosis treatments, therefore, has been preventing fractures.
In a new study, postmenopausal women with osteoporosis who took daily doses of the investigational drug risedronate reduced their risk of new bone fractures, according to an article in the October 13,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Papanicolaou Smears
Is Pap Smear Quality a Sign of Provider Performance? - Breast Cancer (Etiology)
No Evidence To Suggest Cancer Is Linked to Stress - Breast Cancer (Fatigue)
Breast Cancer Patients Are Exhausted - Breast Cancer (Surgery)
Postoperative Pain Common in Breast Cancer Patients - Breast Cancer (Therapy)
Study Identifies Groups Unlikely to Benefit from Intensive Treatment - Cancer Therapies
Radioactive Seeds Localize Biopsy Lesions - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
